• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄分层的普通人群样本中慢性阻塞性肺疾病的七年累积发病率。

Seven-year cumulative incidence of COPD in an age-stratified general population sample.

作者信息

Lindberg Anne, Eriksson Berne, Larsson Lars-Gunnar, Rönmark Eva, Sandström Thomas, Lundbäck Bo

机构信息

Senior Consultant, Division of Respiratory Medicine and Allergy, Department of Medicine, Sunderby Central Hospital of Norrbotten, SE-971 80 Luleå, Sweden.

出版信息

Chest. 2006 Apr;129(4):879-85. doi: 10.1378/chest.129.4.879.

DOI:10.1378/chest.129.4.879
PMID:16608933
Abstract

AIM

To estimate the cumulative incidence of COPD and risk factors related to the development of COPD, including evaluation of the relationship between Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 0 (ie, respiratory symptoms and normal lung function) and the development of COPD, in an age-stratified general population sample of middle-aged and elderly individuals.

METHOD

The third survey of the Obstructive Lung Disease in Northern Sweden studies cohort I (three age strata born in 1919 to 1920, 1934 to 1935, and 1949 to 1950) was performed in 1996, and 5,189 subjects (88%) responded to the postal questionnaire. Of the responders, a random sample (1,500 subjects) was invited to an examination in 1996 and in 2003. A total of 963 subjects performed spirometry on both occasions. COPD was defined according to the spirometric criteria of the GOLD. Two levels of disease severity, grade I and higher (GOLD criteria, FEV(1)/FVC ratio of < 0.70) and also grade II and higher (GOLD II criteria, FEV(1)/FVC ratio of < 0.70 and FEV(1) <80% predicted).

RESULTS

The 7-year cumulative incidence of COPD was 11.0% and 4.9%, respectively, according to GOLD and GOLD II, and was significantly related to smoking (smokers, 18.8% and 10.6%, respectively; ex-smokers, 10.5% and 5.2%, respectively; non-smokers, 7.6% and 1.6%, respectively). Incident COPD according to GOLD, but not according to GOLD II, was significantly associated with increasing age. Most respiratory symptoms at study entry were markers of increased risk for incident COPD when analyzed in a multivariate model adjusting for confounders.

CONCLUSION

The GOLD criteria yielded a higher cumulative incidence (11.0%) compared to the GOLD II (4.9%). Smoking, but not gender, was associated with incident COPD. Most respiratory symptoms at the beginning of the observation period marked an increased risk for developing COPD, thus the classification GOLD stage 0 seems relevant among middle-aged and elderly persons.

摘要

目的

在一个按年龄分层的中老年普通人群样本中,评估慢性阻塞性肺疾病(COPD)的累积发病率以及与COPD发生相关的危险因素,包括评估慢性阻塞性肺疾病全球倡议(GOLD)0期(即呼吸道症状且肺功能正常)与COPD发生之间的关系。

方法

1996年对瑞典北部阻塞性肺疾病研究队列I(三个年龄层,分别出生于1919年至1920年、1934年至1935年和1949年至1950年)进行了第三次调查,5189名受试者(88%)回复了邮寄问卷。在回复者中,随机抽取1500名受试者于1996年和2003年接受检查。共有963名受试者在两个时间点都进行了肺功能测定。COPD根据GOLD的肺功能测定标准进行定义。疾病严重程度分为两级,I级及以上(GOLD标准:FEV(1)/FVC比值<0.70)以及II级及以上(GOLD II标准:FEV(1)/FVC比值<0.70且FEV(1)<预测值的80%)。

结果

根据GOLD和GOLD II标准,COPD的7年累积发病率分别为11.0%和4.9%,且与吸烟显著相关(吸烟者分别为18.8%和10.6%;既往吸烟者分别为10.5%和5.2%;非吸烟者分别为7.6%和1.6%)。根据GOLD标准而非GOLD II标准的新发COPD与年龄增长显著相关。在对混杂因素进行多变量模型分析时,研究开始时的大多数呼吸道症状都是新发COPD风险增加的标志。

结论

与GOLD II标准(4.9%)相比,GOLD标准的累积发病率更高(11.0%)。吸烟而非性别与新发COPD相关。观察期开始时的大多数呼吸道症状表明发生COPD的风险增加,因此GOLD 0期分类在中老年人中似乎是相关的。

相似文献

1
Seven-year cumulative incidence of COPD in an age-stratified general population sample.年龄分层的普通人群样本中慢性阻塞性肺疾病的七年累积发病率。
Chest. 2006 Apr;129(4):879-85. doi: 10.1378/chest.129.4.879.
2
Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort.有症状队列中慢性阻塞性肺疾病(COPD)的十年累积发病率及发病的危险因素
Chest. 2005 May;127(5):1544-52. doi: 10.1378/chest.127.5.1544.
3
Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.根据疾病严重程度对慢性阻塞性肺疾病(COPD)的患病率、诊断不足情况以及吸烟的归因比例:来自瑞典北部阻塞性肺病研究的报告
Respir Med. 2006 Feb;100(2):264-72. doi: 10.1016/j.rmed.2005.04.029. Epub 2005 Jun 21.
4
Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.40至65岁男性吸烟者中中度慢性阻塞性肺疾病(GOLD II级)的发病率及影响因素:5年随访
Br J Gen Pract. 2006 Sep;56(530):656-61.
5
Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.有呼吸道症状队列中,第一秒用力呼气容积(FEV1)下降与慢性阻塞性肺疾病发病的关系
COPD. 2007 Mar;4(1):5-13. doi: 10.1080/15412550601168358.
6
COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies.非吸烟人群中的 COPD - 来自瑞典北部阻塞性肺病(OLIN)研究的报告。
Respir Med. 2012 Jul;106(7):980-8. doi: 10.1016/j.rmed.2012.03.010. Epub 2012 Apr 11.
7
Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.不是15%而是50%的吸烟者会患慢性阻塞性肺疾病?——来自瑞典北部阻塞性肺病研究的报告。
Respir Med. 2003 Feb;97(2):115-22. doi: 10.1053/rmed.2003.1446.
8
Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?老年人的肺功能测试——我们还能将FEV1/FVC<70%作为慢性阻塞性肺疾病(COPD)的标准吗?
Respir Med. 2007 Jun;101(6):1097-105. doi: 10.1016/j.rmed.2006.11.019. Epub 2007 Jan 18.
9
Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults.职业性接触粉尘、气体和烟雾与瑞士成年人空气污染与肺部和心脏疾病队列研究中慢性阻塞性肺疾病的发病关系。
Am J Respir Crit Care Med. 2012 Jun 15;185(12):1292-300. doi: 10.1164/rccm.201110-1917OC. Epub 2012 Apr 6.
10
The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.瑞典乌普萨拉慢性阻塞性肺疾病的患病率——慢性阻塞性肺病负担(BOLD)研究:基于人群的横断面研究
Clin Respir J. 2012 Apr;6(2):120-7. doi: 10.1111/j.1752-699X.2011.00257.x. Epub 2011 Jul 6.

引用本文的文献

1
Natural killer cells in the lung: novel insight and future challenge in the airway diseases.肺中的自然杀伤细胞:气道疾病的新见解与未来挑战
ERJ Open Res. 2025 Mar 10;11(2). doi: 10.1183/23120541.00683-2024. eCollection 2025 Mar.
2
L-Arginine, as an essential amino acid, is a potential substitute for treating COPD via regulation of ROS/NLRP3/NF-κB signaling pathway.L-精氨酸作为一种必需氨基酸,是通过调节ROS/NLRP3/NF-κB信号通路治疗慢性阻塞性肺疾病(COPD)的一种潜在替代物。
Cell Biosci. 2023 Aug 18;13(1):152. doi: 10.1186/s13578-023-00994-9.
3
A Proposal to Differentiate ACO, Asthma and COPD in Vietnam.
越南区分哮喘-慢性阻塞性肺疾病重叠综合征、哮喘和慢性阻塞性肺疾病的一项提议。
J Pers Med. 2022 Dec 29;13(1):78. doi: 10.3390/jpm13010078.
4
Clinical Impact of the Bronchiectasis with Chronic Bronchitis Symptoms in COPD: Analysis of a Longitudinal Cohort.COPD 患者有慢性支气管炎症状的支气管扩张症的临床影响:一项纵向队列分析。
Int J Chron Obstruct Pulmon Dis. 2021 Nov 1;16:2997-3008. doi: 10.2147/COPD.S332299. eCollection 2021.
5
The effect of consecutive ambient air pollution on the hospital admission from chronic obstructive pulmonary disease in the Chengdu region, China.中国成都地区连续环境空气污染对慢性阻塞性肺疾病患者住院率的影响。
Air Qual Atmos Health. 2021;14(7):1049-1061. doi: 10.1007/s11869-021-00998-9. Epub 2021 Mar 18.
6
Decreased COPD prevalence in Sweden after decades of decrease in smoking.瑞典吸烟人数减少数十年来 COPD 患病率下降。
Respir Res. 2020 Oct 28;21(1):283. doi: 10.1186/s12931-020-01536-4.
7
Construction of Potential miRNA-mRNA Regulatory Network in COPD Plasma by Bioinformatics Analysis.通过生物信息学分析构建慢性阻塞性肺疾病血浆中潜在的微小RNA-信使核糖核酸调控网络
Int J Chron Obstruct Pulmon Dis. 2020 Sep 10;15:2135-2145. doi: 10.2147/COPD.S255262. eCollection 2020.
8
Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.瑞典严重 COVID-19 的预后因素负担和流行情况。
Eur J Epidemiol. 2020 May;35(5):401-409. doi: 10.1007/s10654-020-00646-z. Epub 2020 May 18.
9
Bronchial Rheoplasty for Treatment of Chronic Bronchitis. Twelve-Month Results from a Multicenter Clinical Trial.支气管成形术治疗慢性支气管炎。多中心临床试验的 12 个月结果。
Am J Respir Crit Care Med. 2020 Sep 1;202(5):681-689. doi: 10.1164/rccm.201908-1546OC.
10
Prognostic value of first-recorded breathlessness for future chronic respiratory and heart disease: a cohort study using a UK national primary care database.首次记录呼吸困难对未来慢性呼吸和心脏疾病的预后价值:一项使用英国国家初级保健数据库的队列研究。
Br J Gen Pract. 2020 Mar 26;70(693):e264-e273. doi: 10.3399/bjgp20X708221. Print 2020 Apr.